Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul;36(1):12-26.
doi: 10.1007/s12640-019-00030-0. Epub 2019 Apr 4.

Effects of Curcumin on Microglial Cells

Affiliations
Review

Effects of Curcumin on Microglial Cells

Faezeh Ghasemi et al. Neurotox Res. 2019 Jul.

Abstract

Microglia are innate immune system cells which reside in the central nervous system (CNS). Resting microglia regulate the homeostasis of the CNS via phagocytic activity to clear pathogens and cell debris. Sometimes, however, to protect neurons and fight invading pathogens, resting microglia transform to an activated-form, producing inflammatory mediators, such as cytokines, chemokines, iNOS/NO and cyclooxygenase-2 (COX-2). Excessive inflammation, however, leads to damaged neurons and neurodegenerative diseases (NDs), such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). Curcumin is a phytochemical isolated from Curcuma longa. It is widely used in Asia and has many therapeutic properties, including antioxidant, anti-viral, anti-bacterial, anti-mutagenic, anti-amyloidogenic and anti-inflammatory, especially with respect to neuroinflammation and neurological disorders (NDs). Curcumin is a pleiotropic molecule that inhibits microglia transformation, inflammatory mediators and subsequent NDs. In this mini-review, we discuss the effects of curcumin on microglia and explore the underlying mechanisms.

Keywords: Curcumin; Microglia, neuroinflammation; Neurodegenerative diseases; Neuroprotection.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res Dev Brain Res. 1999 Nov 18;117(2):145-52 - PubMed
    1. Anticancer Res. 2001 Jul-Aug;21(4B):2895-900 - PubMed
    1. Clin Cancer Res. 2004 Oct 15;10(20):6847-54 - PubMed
    1. J Immunol. 2005 Oct 1;175(7):4320-30 - PubMed
    1. Immunity. 2005 Oct;23(4):344-6 - PubMed

LinkOut - more resources